LATEST NEWS
TaiGen’s Nemonoxacin Receives US FDA Fast Track Designation
TaiGen Biotech's nemonoxacin has received fast track designation and Qualified Infectious Disease Product status by the US FDA.
MicuRx Expands Clinical Trial Program For Oral Antibiotic MRX-I
MicuRx Pharmaceuticals has initiated a global clinical development program for its lead compound MRX-I.
Researchers Discover Genetic Loci Linked To Rheumatoid Arthritis
The largest international study to date into the genetic basis of rheumatoid arthritis has shed light on how existing drugs target it.
Scientists Discover Gene That Protects Against Nerve Degeneration
Scientists have identified a gene that protects against spontaneous, adult-onset progressive nerve degeneration.
Takeda Terminates Development Of Fasiglifam
Takeda has decided to terminate the development activities for fasiglifam, an investigational treatment for type II diabetes, due to concerns about liver safety.
7 Must-Read Stories In December 2013
Here are seven must-read stories from the December 2013 issue of Asian Scientist Magazine.
Cities Are the Future Of India’s Higher Education
Professor Pushkar of BITS Pilani-Goa discusses the importance of building new universities in cities to raise the quality of higher education in India.
Scientists Identify Genetic Loci For Lynch Syndrome
Scientists can now identify more accurately people at high risk for Lynch Syndrome, an inherited, familial condition that increases the risk of bowel and endometrial cancer.
Sensory Map Development Regulated By Serotonin At Birth
Researchers in Japan have identified how sensory map development is regulated in mice pups at birth.
